Sage Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Cash & Equivalents	74.82	159.56	0.5
Short-Term Investments	439.59	-	-
Cash & Short-Term Investments	514.41	159.56	0.5
Cash Growth	222.39%	31812.60%	-
Accounts Receivable	330.4	294.44	-
Other Receivables	1.78	116.14	-
Receivables	332.19	410.91	-
Inventory	321.48	387.15	-
Prepaid Expenses	9.67	4.01	-
Other Current Assets	21.24	-	0.01
Total Current Assets	1,199	961.62	0.51
Property, Plant & Equipment	1,178	933.95	-
Long-Term Investments	0	-	-
Other Intangible Assets	3.98	6.13	-
Other Long-Term Assets	119.15	124.26	-
Total Assets	2,500	2,026	0.51
Accounts Payable	234.16	216.94	0.05
Accrued Expenses	113.14	101.61	-
Current Portion of Long-Term Debt	48.12	24.83	-
Current Portion of Leases	14.11	12.53	-
Current Income Taxes Payable	94.75	101.17	-
Other Current Liabilities	111.18	51.4	0.08
Total Current Liabilities	615.46	508.47	0.13
Long-Term Debt	148.71	29.42	-
Long-Term Leases	13.89	21.6	-
Long-Term Deferred Tax Liabilities	47.15	23.68	-
Other Long-Term Liabilities	12.62	21.77	-
Total Liabilities	837.83	648.43	0.13
Common Stock	515.95	515.95	0.5
Retained Earnings	1,535	1,248	-0.12
Comprehensive Income & Other	-388.96	-386.4	-
Shareholders' Equity	1,662	1,378	0.38
Total Liabilities & Equity	2,500	2,026	0.51
Total Debt	224.83	88.37	-
Net Cash (Debt)	289.58	71.2	0.5
Net Cash Growth	306.72%	14139.60%	-
Net Cash Per Share	5.61	26.51	10.00
Filing Date Shares Outstanding	51.59	51.59	0.05
Total Common Shares Outstanding	51.59	51.59	0.05
Working Capital	583.53	453.16	0.38
Book Value Per Share	32.22	26.70	7.64
Tangible Book Value	1,658	1,371	0.38
Tangible Book Value Per Share	32.14	26.58	7.64
Buildings	447.13	446.83	-
Machinery	2,004	1,810	-
Construction In Progress	81.98	46.87	-

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.